BS
Congress trade
Rep. Bradley Schneider (D-IL) bought $100K-$250K of Celgene Corporation (CELG) stock
Bradley Schneider, U.S. Representative (D-IL), disclosed a purchase of Celgene Corporation (CELG) stock worth $100K-$250K in a STOCK Act filing on Feb 20, 2017.
The trade happened on Jan 9, 2017, 42 days before it was made public.
- Traded
- Jan 9, 2017
- Disclosed
- Feb 20, 2017
- Filing delay
- 42 days
- Source
- STOCK Act disclosure
Other trades in this disclosure (6)
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.